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goals of individuals and communities 
to achieve optimum quality and 
quantity of life. There is increasing 
evidence that such a health system 
should be based on strong primary 
health care, that uses an eff ective 
community-oriented primary care 
model,4 addressing ways to reduce the 
causes of NCDs and tackling social and 
political issues at the local, national, 
and international level because of its 
emphasis on community input. 
Earlier this year, Richard Horton5 
commented that “There has been 
an argument for several decades 
now to drop vertical disease 
programmes...and replace them 
with schemes that emphasise 
health systems strengthening... 
Health systems approaches to aid 
may be intellectually correct, but 
they are politically problematic.” A 
comprehensive integrated strategy 
based on primary health care to tackle 
NCDs creates a unique opportunity to 
make the switch.
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Non-specifi c low back 
pain
In their Seminar on low back pain, 
Federico Balagué and colleagues (Feb 4, 
p 482)1 conclude that (occu pational) 
mechanical factors are unlikely to be 
independently causative of low back 
pain. This far-reaching conclusion 
is based on reviews of published 
epidemiological studies and on the 
relation between evidence of tissue 
injury on imaging and low back pain.
In terms of epidemiology, Balagué 
and colleagues base their conclusion 
on a series of reviews by Wai, Roff ey, 
Bishop, Kwon, and Dagenais. These 
reviews have been criticised for 
several reasons.2,3 First, they rely 
on application of the Bradford-Hill 
criteria to single epidemiological 
studies, whereas these criteria were 
proposed to help assess the evidence 
for causality across studies from 
diff erent disciplines. Second, other 
reviews4 have reached contrasting 
conclusions. Third, in the studies 
on which the reviews were based, 
exposure to mechanical loading was 
incomplete—ie, not encompassing 
intensity, frequency, and duration—
and was based on inaccurate proxy 
measures. Where exposure has been 
better characterised, strong relations 
are seen.5
Balagué and colleagues furthermore 
use the lack of a one-to-one relation 
between back pain and structural 
damage to the spine as an argument 
against the relevance of mechanical 
injury in the origin of low back pain. 
Such an argument could be used 
similarly to deny the relation between 
smoking and lung cancer.
Neglect of occupational, mechanical 
loading as a causal factor in low back 
pain is not based on evidence and 
might seriously hamper eff ective 
prevention and management.
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Authors’ reply
Before we respond to the issues raised 
by J H van Dieën and colleagues, we 
would like to point out a couple of 
minor inaccuracies in their letter. Our 
Seminar was not about “low back pain” 
(all-cause) but about non-specifi c low 
back pain, as defi ned in the opening 
paragraph. This is not just a semantic 
issue. There is an important distinction 
between the two, and one that is 
highly relevant in this context. The 
biological plausibility of a mechanical 
role in (some) back pain—on the basis 
of experimental or laboratory studies 
including those by van Dieën and 
colleagues—mainly concerns specifi c 
types of low back injury such as acute 
prolapsed disc, fracture, etc. The second 
inaccuracy is that our conclusion 
(p 488) makes no reference to any 
specifi c causative factors in back pain; it 
acknowledges the eff ect of physical and 
environ mental factors, among others.
We have read the earlier letters 
by van Dieën, Kuijer, and others 
criticising the Dagenais group’s 
systematic reviews and we refer the 
interested reader to the eloquent 
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rebuttals provided by the authors of 
those reviews.
Our colleagues might not be 
familiar with the specifi cations given 
to authors in writing for The Lancet’s 
Seminar series. The remit is to create 
an article that is “clinically focused 
and up-to-date”, with a limit on the 
number of words and the quantity, 
nature, and age of the references 
cited. Owing to their uppermost 
position in the hierarchy of evidence, 
systematic reviews are relied on 
heavily. These prerequisites preclude 
detailed discussion of the strengths 
and weaknesses of the cited works. 
Our aim was to fulfi l our remit while 
stimulating refl ection and further 
enquiry by the interested reader.
In the Seminar, we highlight 
the fact that epidemiological 
studies do not seem to support the 
notion of mechanical factors being 
independently causative of low back 
pain. Despite the enormous amount 
of research done in the specialty of 
biomechanics and ergonomics, there 
has been no notable improvement in 
the burden of non-specifi c low back 
pain. As clinicians, we are acutely aware 
of the potentially detrimental side-
eff ects of repeated messages about 
“ergonomically correct behaviour” 
that in some patients merely serve 
to promote kinesiophobia or fear 
avoidance behaviour.
With respect, we think the analogy 
with smoking and lung cancer is rather 
trite; one need only to look at an-
other important Bradford-Hill aspect of 
causality, “experiment (reversibility)”, 
to realise that the benefi ts of ergo-
nomic prevention programmes for 
back pain1 are in no way comparable to 
those of smoking cessation for cancer.2,3
Concerning the fi nal paragraph of 
van Dieën and colleagues’ letter, we 
deny any suggestion that occupa-
tional, mechanical loading should 
be neglected within the context 
of low back pain; however, for the 
aforementioned reasons, together 
with the fi nding that a high pro por-
tion of teenagers report non-specifi c 
low back pain (yet have zero expo-
sure to occupational loading) and 
data apportioning the contribution 
of sus pected explanatory variables 
(gen etic, mechanical, other),4,5 we 
maintain that a major causal role 
for occupational, mechanical loading 
remains questionable.
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trial diffi  cult, especially when these 
fi gures are compared with those 
reported in Smith and colleagues’ 
previous study (BALTI),2 which was 
used to calculate the sample size.
The observed mortality rates (23% 
in the placebo group and 34% in 
the intervention group) are lower 
than those predicted by the severity 
of illness (assessed by the Acute 
Physiology and Chronic Health 
Evaluation [APACHE II]), resulting in 
very low standardised mortality ratios 
(0·54 in the placebo group and 0·79 
in the treated group). The observed 
mortality rates are also diff erent from 
the fi gures reported in the BALTI 
study: 66% and 58% in the placebo 
and treated groups, respectively. 
These data raise a logical question 
as to the true severity of disease in 
these patients, and whether these 
fi ndings should be extrapolated to 
real life. Indeed, although BALTI-2 
included patients with the most 
severe disease (only ARDS, whereas 
those with either acute lung injury or 
ARDS were included in BALTI), Smith 
and colleagues reported similar PaO2/
FiO2 ratios, lower APACHE II score, and 
overall a very low 28-day mortality.1
Moreover, careful examination of 
the survival curve shows that there 
was a non-signifi cant increase in 
mortality during the drug infusion 
period (up to 7 days): 9·1% and 9·2% 
mortality by day 6 in the treated 
group and in the placebo group, 
respectively. This fi nding adds to the 
diffi  culties in interpreting the results 
of this study.
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Intravenous salbutamol 
in ARDS and increased 
mortality
In the BALTI-2 trial, Fang Gao Smith 
and colleagues (Jan 21, p 229)1 report 
an increase in 28-day mortality 
after a 7-day infusion of salbutamol 
compared with placebo in patients 
with early acute respiratory distress 
syndrome (ARDS). Major discrepancies 
between predicted and observed 
mortality make interpretation of this 
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